Zhengyan Yang

1.1k total citations
37 papers, 807 citations indexed

About

Zhengyan Yang is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Zhengyan Yang has authored 37 papers receiving a total of 807 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 12 papers in Oncology and 5 papers in Pharmacology. Recurrent topics in Zhengyan Yang's work include Cancer, Stress, Anesthesia, and Immune Response (5 papers), Cancer Cells and Metastasis (5 papers) and Fungal Biology and Applications (5 papers). Zhengyan Yang is often cited by papers focused on Cancer, Stress, Anesthesia, and Immune Response (5 papers), Cancer Cells and Metastasis (5 papers) and Fungal Biology and Applications (5 papers). Zhengyan Yang collaborates with scholars based in China, Fiji and United States. Zhengyan Yang's co-authors include Ning Guo, Xunxiang Du, Ming Shi, David A. Williams, Attilio Orazi, Liang Guo, Dan Liu, Yuanfang Ma, Ming Yu and Meiru Hu and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Oncogene.

In The Last Decade

Zhengyan Yang

36 papers receiving 791 citations

Peers

Zhengyan Yang

ONCOL

PMH

IMMUN

Safieh Ebrahimi Iran

Yawei Tang China

Lili Huang China

Jacques Abello France

Minsub Shim United States

Pattatheyil Arun India

Yehua Li China

Éric Chevalier United States

Rui Feng China

Teresa Barlozzari United States

Safieh Ebrahimi Iran

Zhengyan Yang

334 ×1.0

187 ×0.7

ONCOL

162 ×1.2

84 ×0.6

PMH

57 ×0.5

IMMUN

Citations per year, relative to Zhengyan Yang Zhengyan Yang (= 1×) peers Safieh Ebrahimi

Countries citing papers authored by Zhengyan Yang

Since Specialization

Citations

This map shows the geographic impact of Zhengyan Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhengyan Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhengyan Yang more than expected).

Fields of papers citing papers by Zhengyan Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhengyan Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhengyan Yang. The network helps show where Zhengyan Yang may publish in the future.

Co-authorship network of co-authors of Zhengyan Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Zhengyan Yang. A scholar is included among the top collaborators of Zhengyan Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhengyan Yang. Zhengyan Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yu, Jiahui, et al.. (2025). Hydroxysafflower yellow a protects against UVA- and UVB-induced skin aging by suppressing cell apoptosis and SASP via targeting JNK and p38 MAPK pathway. Journal of Photochemistry and Photobiology B Biology. 274. 113340–113340.

Xia, Rong, et al.. (2024). Potential key pathophysiological participant and treatment target in autism spectrum disorder: Microglia. Molecular and Cellular Neuroscience. 131. 103980–103980. 2 indexed citations

Xu, Peng, Tang‐Lin Liu, Zhengyan Yang, et al.. (2024). P2RY6 deletion promotes UVB‐induced skin carcinogenesis by activating the PI3K/AKT signal pathway. Cancer Science. 116(1). 56–66. 1 indexed citations

Deng, Xubin, Qianbing Zhang, Fa Jin, et al.. (2024). Ailanthone disturbs cross-talk between cancer cells and tumor-associated macrophages via HIF1-α/LINC01956/FUS/β-catenin signaling pathway in glioblastoma. Cancer Cell International. 24(1). 397–397. 1 indexed citations

Yang, Zhengyan, Pai Zhang, Zhi Zhao, et al.. (2024). DRD4 promotes chemo-resistance and cancer stem cell-like phenotypes by mediating the activation of the Akt/β-catenin signaling axis in liver cancer. British Journal of Cancer. 131(7). 1212–1223. 6 indexed citations

Yang, Zhengyan, et al.. (2023). Oral microbial communities in 5-year-old children with versus without dental caries. BMC Oral Health. 23(1). 400–400. 10 indexed citations

Li, Kejia, Mingli Wang, Hui Li, et al.. (2022). Biotin attenuates heat shock factor 4b transcriptional activity by lysine 444 biotinylation. Biochemistry and Biophysics Reports. 30. 101227–101227. 1 indexed citations

Li, Meng, et al.. (2022). The circadian clock gene ARNTL overexpression suppresses oral cancer progression by inducing apoptosis via activating autophagy. Medical Oncology. 39(12). 244–244. 10 indexed citations

Cui, Xiukun, Dandan Wu, Jing Zhang, et al.. (2021). Deficiency of heat shock factor 4 promotes lens epithelial cell senescence through upregulating p21cip1 expression. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1867(11). 166233–166233. 7 indexed citations

10.

Zhang, Huijuan, Wenjing Chang, Jing Zhou, et al.. (2020). Destrin Contributes to Lung Adenocarcinoma Progression by Activating Wnt/β-Catenin Signaling Pathway. Molecular Cancer Research. 18(12). 1789–1802. 29 indexed citations

11.

Ren, Zhiguang, Yongkun Zhao, Jing Liu, et al.. (2018). Intramuscular and intranasal immunization with an H7N9 influenza virus-like particle vaccine protects mice against lethal influenza virus challenge. International Immunopharmacology. 58. 109–116. 16 indexed citations

12.

Ren, Zhiguang, Yongkun Zhao, Jing Liu, et al.. (2018). Inclusion of membrane-anchored LTB or flagellin protein in H5N1 virus-like particles enhances protective responses following intramuscular and oral immunization of mice. Vaccine. 36(40). 5990–5998. 16 indexed citations

13.

Yang, Zhengyan, Yi Hu, Chao Hu, et al.. (2015). β2-AR signaling controls trastuzumab resistance-dependent pathway. Oncogene. 35(1). 47–58. 75 indexed citations

14.

Liu, Dan, Limin Sun, Tao Wang, et al.. (2015). A Her2-let-7-β2-AR circuit affects prognosis in patients with Her2-positive breast cancer. BMC Cancer. 15(1). 832–832. 24 indexed citations

15.

Liu, Dan, Ming Shi, Chenyang Duan, et al.. (2013). Downregulation of Erbin in Her2-overexpressing breast cancer cells promotes cell migration and induces trastuzumab resistance. Molecular Immunology. 56(1-2). 104–112. 17 indexed citations

16.

Shi, Ming, Dan Liu, Zhengyan Yang, & Ning Guo. (2013). Central and peripheral nervous systems: master controllers in cancer metastasis. Cancer and Metastasis Reviews. 32(3-4). 603–621. 31 indexed citations

17.

Hu, Yuan‐Chao, Chenyang Duan, Qian Lü, et al.. (2013). Deficiency of Erbin induces resistance of cervical cancer cells to anoikis in a STAT3-dependent manner. Oncogenesis. 2(6). e52–e52. 27 indexed citations

18.

Shi, Ming, Dan Liu, Qian Lü, et al.. (2012). Glucocorticoid regulation of a novel HPV–E6–p53– miR‐145 pathway modulates invasion and therapy resistance of cervical cancer cells. The Journal of Pathology. 228(2). 148–157. 69 indexed citations

19.

Shi, Ming, Meiru Hu, Dan Liu, et al.. (2012). β2-AR-induced Her2 transactivation mediated by Erbin confers protection from apoptosis in cardiomyocytes. International Journal of Cardiology. 167(4). 1570–1577. 22 indexed citations

20.

Yang, Zhengyan, et al.. (2005). Study of the gene expression profile of human ovarian carcinoma by a gene chip. Chinese Journal of Clinical Oncology. 2(3). 662–670. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact